Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis

Gagandeep Brar, Tim F. Greten, Barry I. Graubard, Timothy S. McNeel, Jessica L. Petrick, Katherine A. McGlynn, Sean F. Altekruse – 9 August 2020 – In the United States, hepatocellular carcinoma (HCC) survival varies with tumor characteristics, patient comorbidities, and treatment. The effect of HCC etiology on survival is less clearly defined. The relationship between HCC etiology and mortality was examined using Surveillance, Epidemiology, and End Results–Medicare data.

Coronary Computed Tomography Angiography Demonstrates a High Burden of Coronary Artery Disease Despite Low‐Risk Nuclear Studies in Pre–Liver Transplant Evaluation

Adrián I. Löffler, Jorge A. Gonzalez, Shriram K. Sundararaman, Roshin C. Mathew, Patrick T. Norton, Klaus D. Hagspiel, Christopher M. Kramer, Michael Ragosta, Campbell Rogers, Neeral L. Shah, Michael Salerno – 9 August 2020 – We investigated the presence and severity of coronary artery disease (CAD) in orthotopic liver transplantation (OLT) candidates using coronary artery calcium score (CACS) and coronary computed tomography angiography (CCTA) as compared with the prevalence of normal and abnormal single‐photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI).

Developmental Programming of NAFLD by Parental Obesity

Michael D. Thompson – 9 August 2020 – The surge of obesity across generations has become an increasingly relevant issue, with consequences for associated comorbidities in offspring. Data from longitudinal birth cohort studies support an association between maternal obesity and offspring nonalcoholic fatty liver disease (NAFLD), suggesting that perinatal obesity or obesogenic diet exposure reprograms offspring liver and increases NAFLD susceptibility.

Subscribe to